Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/14/2012US20120150096 Implantable or insertable medical devices for controlled drug delivery
06/14/2012US20120150033 Antimicrobial ultrasound transmission gel
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149780 Method of Use of Vitamin K as Energy Enhancer in Diverse Disease States
06/14/2012US20120149779 High concentration local anesthetic formulations
06/14/2012US20120149778 Compounds
06/14/2012US20120149777 Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
06/14/2012US20120149776 Preparation for sun protection
06/14/2012US20120149775 Methods for preventing and improving skin elastic property loss
06/14/2012US20120149774 Compositions and methods for nutrient delivery
06/14/2012US20120149773 Composition for skin improvement comprising hexamidines and retinoids
06/14/2012US20120149772 Process for the preparation of fesoterodine or a salt thereof
06/14/2012US20120149771 Method for treating airway hyper-responsiveness with lipoxin analogs
06/14/2012US20120149770 Antimicrobial Preservation of Propofol Emulsions
06/14/2012US20120149769 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders
06/14/2012US20120149768 Pkc-activating compounds for the treatment of neurodegenerative diseases
06/14/2012US20120149767 Connection Device for a Submersible Connector
06/14/2012US20120149766 Dietary and pharmaceutical compositions comprising a sage extract containing a mixture of tricyclic diterpenes and their derivatives and their uses
06/14/2012US20120149765 Sgk1 as diagnostic and therapeutic target
06/14/2012US20120149764 Aptamers that bind thrombin with high affinity
06/14/2012US20120149763 Pharmaceutical composition for treating adverse reactions due to administration of spiegelmers
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149761 Nucleic acid molecules and uses thereof
06/14/2012US20120149760 Disabling autophagy as a treatment for lysosomal storage diseases
06/14/2012US20120149759 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
06/14/2012US20120149758 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
06/14/2012US20120149757 Compositions and methods for modulation of smn2 splicing
06/14/2012US20120149756 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149754 Methods for modulating the expression and aggregation of cag-expanded gene product in cells and methods for identifying agents useful for doing the same
06/14/2012US20120149753 Use of novel compounds from fruiting body of antrodia camphorata for treating an inflammatory disorder
06/14/2012US20120149752 Kit for balancing neurotransmitter levels
06/14/2012US20120149751 Antiviral Drugs for Treatment of Arenavirus Infection
06/14/2012US20120149750 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
06/14/2012US20120149749 Method of treating thrombocytopenia
06/14/2012US20120149748 Pharmaceutical Cream Compositions and Methods of Use
06/14/2012US20120149747 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
06/14/2012US20120149746 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
06/14/2012US20120149745 Antimycotic pharmaceutical composition
06/14/2012US20120149744 Anti-mitotic anti-proliferative compounds
06/14/2012US20120149743 Selenophene and Selenazole Carboxylic Acid Derivatives
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149741 Treatment of duchenne muscular dystrophy
06/14/2012US20120149740 Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/14/2012US20120149739 Pharmaceutical depot for n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
06/14/2012US20120149738 Novel inhibitors of proliferation and activation of signal transducer and activators of transcription (stats)
06/14/2012US20120149737 Therapeutic Aryl-Amido-Aryl Compounds and Their Use
06/14/2012US20120149736 Enzyme inhibitors
06/14/2012US20120149735 1,4-Dihydropyridine Derivatives and Their Uses
06/14/2012US20120149734 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149731 New medical use
06/14/2012US20120149730 Methods and compositions using racemic, (r)-, and (s)-fexofenadine in combination with leukotriene inhibitors
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149728 Novel fumarate salts of a histamine h3 receptor antagonist
06/14/2012US20120149727 Prasugrel in non-crystalline form and pharmaceutical composition thereof
06/14/2012US20120149726 Crystal Forms of Kinase Inhibitors
06/14/2012US20120149725 Anhydrate ot tiotropium bromide
06/14/2012US20120149724 Modulating endogenous beta-endorphin levels
06/14/2012US20120149723 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
06/14/2012US20120149722 Heteroaryl compounds and uses thereof
06/14/2012US20120149721 Methylpyrrolopyrimidinecarboxamides
06/14/2012US20120149720 Valacyclovir formulations
06/14/2012US20120149719 Bitter taste masking dosage form
06/14/2012US20120149718 Amido Compounds
06/14/2012US20120149717 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
06/14/2012US20120149716 Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
06/14/2012US20120149715 Compounds and methods for the treatment of viral infections
06/14/2012US20120149714 Effects of Inhibitors of FGFR3 on Gene Transcription
06/14/2012US20120149713 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl) piperazin-1-l]butoxy]-3,4-dihydro-1h-quinolin-2-one base or salts or hydrates thereof
06/14/2012US20120149712 Methods for improving kidney function
06/14/2012US20120149711 Piperidine derivatives used as orexin antagonists
06/14/2012US20120149710 Sortase a inhibitors
06/14/2012US20120149709 Pyrazinoisoquinoline compounds
06/14/2012US20120149708 Modulators of viral transcription, and methods and compositions therewith
06/14/2012US20120149707 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
06/14/2012US20120149706 Inhibition of p38 kinase activity using substituted heterocyclic ureas
06/14/2012US20120149704 Disubstituted benzamide derivatives as glucokinase (gk) activators
06/14/2012US20120149703 Aza-substituted spiro derivatives
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149699 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS
06/14/2012US20120149698 Nouvel compounds
06/14/2012US20120149697 Humic substances and therapeutic uses thereof
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149695 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
06/14/2012US20120149694 Substituted piperidines
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149692 In Vivo Studies of Crystalline Forms of Meloxicam
06/14/2012US20120149691 Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors
06/14/2012US20120149690 Compositions Comprising Azelastine and Methods of Use Thereof
06/14/2012US20120149689 Method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149687 Heterocyclic compounds and uses thereof
06/14/2012US20120149686 Kinase inhibitors and method of treating cancer with same
06/14/2012US20120149685 Composition and method for the treatment of tauopathies
06/14/2012US20120149684 Akt inhibitors
06/14/2012US20120149683 Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
1 ... 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 ... 7860